There was a slew of COVID-19 vaccine approvals in India in late December. In China, the focus was on investigational therapeutics.
Coronavirus Notebook: Vaccine Approvals In India Amid Wins And Losses For Drug Developers In China
India has issued emergency approvals for a number of new COVID-19 vaccines and extended eligible age groups for others, while developers of potential drug therapies in China have seen both gains and setbacks.
